Glimigrand MV 2.3 Tablet 15 Tablets

Glimigrand MV 2.3 Tablet 15 Tablets

Prescription drug
Manufacturer / Marketer : D EARTH PHARMACEUTICALS
About: Glimigrand MV 2.3 Tablet is an oral antidiabetic medicine used to manage type 2 diabetes mellitus when diet, exercise and monotherapy are insufficient. It combines three agents—glimepiride, metformin and voglibose—to provide comprehensive blood glucose control, particularly post‑meal spikes.
Usage Instructions Take the tablet just before or with main meals as directed by your diabetologist to reduce gastrointestinal side effects and control post‑prandial glucose. Swallow whole with water and do not skip meals after taking the dose to avoid hypoglycaemia.
Benefits Helps lower both fasting and post‑meal blood sugar, reducing the risk of diabetes‑related complications when used with lifestyle measures. The three‑drug combination can reduce the need for multiple separate tablets and improve treatment convenience.
How it Works Glimepiride stimulates the pancreas to release more insulin, metformin decreases hepatic glucose production and improves insulin sensitivity, and voglibose delays carbohydrate absorption from the intestine. Together they help prevent sudden rises in blood sugar after meals and maintain overall glycaemic control.
Side Effects Common side effects include hypoglycaemia (low blood sugar), nausea, diarrhoea, abdominal discomfort, flatulence and headache. Seek immediate help if you experience severe hypoglycaemia symptoms, lactic acidosis signs (deep breathing, muscle pain, extreme weakness) or allergic reactions.
Safety Advice Not recommended in type 1 diabetes, severe kidney or liver dysfunction, or diabetic ketoacidosis. Regular monitoring of blood glucose, kidney function and adherence to diet and exercise is essential; avoid alcohol excess.
Storage Store at room temperature away from excess heat and moisture in the original strip. Keep out of reach of children.
₹210.94
Inclusive of all taxes
Quantity

Expiry Icon
Fresh Stock
Guaranteed
Return Icon
Secure & Hygienic
Packaging
Authentic Icon
Verified & Trusted
Supplements
Quality Icon
Secure
Payment
About: Glimigrand MV 2.3 Tablet is an oral antidiabetic medicine used to manage type 2 diabetes mellitus when diet, exercise and monotherapy are insufficient. It combines three agents—glimepiride, metformin and voglibose—to provide comprehensive blood glucose control, particularly post‑meal spikes.
Usage Instructions Take the tablet just before or with main meals as directed by your diabetologist to reduce gastrointestinal side effects and control post‑prandial glucose. Swallow whole with water and do not skip meals after taking the dose to avoid hypoglycaemia.
Benefits Helps lower both fasting and post‑meal blood sugar, reducing the risk of diabetes‑related complications when used with lifestyle measures. The three‑drug combination can reduce the need for multiple separate tablets and improve treatment convenience.
How it Works Glimepiride stimulates the pancreas to release more insulin, metformin decreases hepatic glucose production and improves insulin sensitivity, and voglibose delays carbohydrate absorption from the intestine. Together they help prevent sudden rises in blood sugar after meals and maintain overall glycaemic control.
Side Effects Common side effects include hypoglycaemia (low blood sugar), nausea, diarrhoea, abdominal discomfort, flatulence and headache. Seek immediate help if you experience severe hypoglycaemia symptoms, lactic acidosis signs (deep breathing, muscle pain, extreme weakness) or allergic reactions.
Safety Advice Not recommended in type 1 diabetes, severe kidney or liver dysfunction, or diabetic ketoacidosis. Regular monitoring of blood glucose, kidney function and adherence to diet and exercise is essential; avoid alcohol excess.
Storage Store at room temperature away from excess heat and moisture in the original strip. Keep out of reach of children.

Related Products